JARED FERNSLER: Open Payments
NPI 1679100978 · ADRIAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 30 payments from 10 companies in 2025. Trend: 2023 $279 · 2024 $485 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $178 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Lilly USA, LLC | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $42 |
| PFIZER INC. | 1 | $23 |
| Bioventus LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $13 |
Products named: VRAYLAR, MOUNJARO, AIRSUPRA, SHINGRIX, Rybelsus, PREVNAR 20, XCELL, Symbravo.
Industry payments across MI — which companies pay providers there.
